Molecular markers of Rathke’s cleft cysts and their clinical correlates: insights from experimental and human analyses

Key Points

• This research aims to verify the expression of molecular markers in human Rathke's cleft cysts and their clinical implications.
• Analyzed expression of six molecular markers identified in Isl-1 knockout mice in human RCCs.
• Evaluated KRT8 and FOXA1 staining for differential diagnosis from craniopharyngiomas.
• Investigated FOXJ1 and TUBA1A expression profiles in relation to hypopituitarism and AVP deficiency.
• KRT8 and FOXA1 help differentiate RCCs from craniopharyngiomas through distinct staining patterns.
• FOXJ1 expression is associated with insights into hypopituitarism mechanisms.
• TUBA1A is related to understanding AVP deficiency, highlighting the importance of these markers.

Abstract